Press

Shyft Aebi Merger Logo

The Shyft Group and Aebi Schmidt Group Announce Successful Completion of Merger, Creating Global Specialty Vehicle Leader

Combined company named Aebi Schmidt Group Trading on NASDAQ expected to begin July 1, 2025 Shyft common stock delisted from Nasdaq NOVI, Mich., July 1, 2025 /PRNewswire/ –The Shyft Group, Inc. (NASDAQ: SHYF) (“Shyft”), the North American leader in specialty vehicle manufacturing, assembly, and upfit for the commercial, retail, and service markets, today announced the […]

The Shyft Group and Aebi Schmidt Group Announce Successful Completion of Merger, Creating Global Specialty Vehicle Leader Read Post »

Press
HyBryte Logo

Soligenix Announces Synthetic Hypericin Successfully Manufactured at Sterling Pharma Solutions

Active Ingredient Manufacturing Transfer to the U.S. Complete  PRINCETON, N.J., July 1, 2025 /PRNewswire/ — Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that it has successfully completed the transfer of the manufacturing

Soligenix Announces Synthetic Hypericin Successfully Manufactured at Sterling Pharma Solutions Read Post »

Press
Broadridge 2023 Logo

Broadridge Announces Expanded Roles for Senior Leaders

Doug DeSchutter and Tom Carey to take on new responsibilities NEW YORK, July 1, 2025 /PRNewswire/ — Broadridge Financial Solutions, Inc. (NYSE: BR), a global Fintech leader, today announced expanded roles for two senior members of its leadership team to support Broadridge’s continued evolution to a platform company. The changes are effective as of July 1. 

Broadridge Announces Expanded Roles for Senior Leaders Read Post »

Press

Trevi Therapeutics to Attend Leerink Partners Therapeutics Forum: I&I and Metabolism

NEW HAVEN, Conn., July 1, 2025 /PRNewswire/ — Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine ER) for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF) and in patients with refractory chronic cough (RCC), today announced that Jennifer Good, President and Chief Executive Officer,

Trevi Therapeutics to Attend Leerink Partners Therapeutics Forum: I&I and Metabolism Read Post »

Press
Alphyn Biologics LLC Logo Hi Res Transparent Bckgrd Logov1

Alphyn’s Zabalafin Hydrogel for Atopic Dermatitis Highlighted in Leading Peer-Reviewed Journal

Expert dermatologist panel creates new atopic dermatitis (AD) algorithm (stepped diagnosis and treatment recommendations) emphasizing need for therapeutics that address AD’s intense itch, inflammation, and the AD disease stages of Staphylococcus aureus (Staph) colonization through infection Panel underscores unmet need for topical multi-target therapeutic such as investigational new drug candidate Zabalafin Hydrogel to meet this need

Alphyn’s Zabalafin Hydrogel for Atopic Dermatitis Highlighted in Leading Peer-Reviewed Journal Read Post »

Press
Huawei s booths Hall N1 MWC Shanghai 2025

10 miljoen 5G-A gebruikers in China: Huawei demonstreert de ontwikkeling van 5G-A en de waarde van op scenario’s gebaseerde AI

SHANGHAI, 1 juli 2025 /PRNewswire/ — Tijdens MWC Shanghai 2025 demonstreerde Huawei nieuwe ontwikkelingen op gebied van 5G Advanced (5G-A) experience monetization en op scenario’s gebaseerde services ondersteund door AI agents. Tijdens het evenement van dit jaar pakte het bedrijf uit met een voorstelling getiteld “Accelerating the Intelligent World”, verwijzend naar het voornemen om met wereldwijde carriers,

10 miljoen 5G-A gebruikers in China: Huawei demonstreert de ontwikkeling van 5G-A en de waarde van op scenario’s gebaseerde AI Read Post »

Press
Christmas in July Sale 2

Will Tariff-Induced Supply Chain Unpredictability Grinch-ify ‘Christmas in July’?

UT Haslam supply chain expert weighs how tariffs may affect Amazon Prime Day and other July sales events. KNOXVILLE, Tenn., July 1, 2025 /PRNewswire/ — In last year’s 48-hour window, Amazon Prime Day set a record of $14.2 billion in sales revenue. The online retail giant has increased the duration of its biggest sales event of

Will Tariff-Induced Supply Chain Unpredictability Grinch-ify ‘Christmas in July’? Read Post »

Press
Scroll to Top